Li, Y., Bedi, R. K., Ojeda-May, P., & Caflisch, A. (2026). Recognition loop dynamics differentiates m6A-mRNA reader domains of YTHDF proteins. Journal of Chemical Theory and Computation, 20(22), 10988–11003. https://doi.org/10.1021/acs.jctc.6c01247 (Original work published)

Li, Y., Bedi, R. K., Nai, F., von Roten, V., Dolbois, A., Zálešák, F., … Caflisch, A. (2022). Structure-based design of ligands of the m6A-RNA reader YTHDC1. European Journal of Medicinal Chemistry Reports, 5, 100057. https://doi.org/https://doi.org/10.1016/j.ejmcr.2022.100057

Bedi, R. K., Huang, D., Eberle, S. A., Wiedmer, L., Śledź, P., & Caflisch, A. (2020). Small-molecule inhibitors of METTL3, the major human epitranscriptomic writer. ChemMedChem, 15(9), 744-748. https://doi.org/10.1002/cmdc.202000011 (Original work published)

Bedi, R. K., Huang, D., Wiedmer, L., Li, Y., Dolbois, A., Wojdyla, J. A., … Śledź, P. (2020). Selectively disrupting m6A-dependent protein-RNA interactions with fragments. ACS Chemical Biology, 15(3), 618-625. https://doi.org/10.1021/acschembio.9b00894 (Original work published)

Li, Y., Bedi, R. K., Wiedmer, L., Huang, D., Śledź, P., & Caflisch, A. (2019). Flexible binding of m6A reader protein YTHDC1 to its preferred RNA motif. Journal of Chemical Theory and Computation, 15(12), 7004-7014. https://doi.org/10.1021/acs.jctc.9b00987 (Original work published)

Marchand, J.-R., & Caflisch, A. (2018). In silico fragment-based drug design with SEED. European Journal of Medicinal Chemistry, 156, 907-917. https://doi.org/10.1016/j.ejmech.2018.07.042 (Original work published)